key: cord-1037275-edtwvaww authors: Subramanyam, Kodangala; Johny, Dilip; Bhat, Suresh; Raghothama, Srivatsa title: De novo right ventricular thrombus in a COVID-19-positive patient date: 2021-11-18 journal: BMJ Case Rep DOI: 10.1136/bcr-2021-247380 sha: be473ff12f15b53f015f2b4d9c53e88561308f1e doc_id: 1037275 cord_uid: edtwvaww nan De novo Right Ventricular (RV) thrombus is unusual in patients with COVID-19. The presence of RV thrombus is usually associated with thromboembolic phenomena happening from Deep Vein Thrombosis (DVT). A 56-year-old woman, known diabetic and hypertensive, was admitted with 1-week history of fever, cough and 3 days of breathlessness. She was severely hypoxemic with an oxygen saturation of 80%. Her reverse transcription-PCR test was positive for SARS-CoV-2. Chest X-ray was suggestive of COVID-19 pneumonia. She was started on parenteral steroids (methylprednisolone 40 mg two times per day), parenteral antibiotics (piperacillin with tazobactam), antivirals (remdesivir 100 mg for 5 days) and anticoagulation (low-molecular weight heparin 60 mg subcutaneously two times per day) along with oxygen therapy. As she became more hypoxemic, she was put on non-invasive ventilation, but subsequently needed mechanical ventilation and inotropic support. Her two-dimensional and three-dimensional transthoracic echocardiography (figures 1A,B and 2) (videos 1-3) showed a de novo RV mobile thrombus (type C), 1 12×12 mm size was seen attached to the RV lateral wall. She had moderate pulmonary arterial hypertension (pulmonary artery systolic pressure-55 mm Hg). Pulmonary arteries appeared normal in calibre and free of thrombus up to the extent visualised. Left ventricular ejection fraction was 45% with regional wall motion abnormality noted in the apex and anterior septum. Two-dimensional transthoracic echocardiography shows four-chamber view with right ventricular type C mobile thrombus (marked in red arrow). No pericardial effusion was seen. Both the lower limb venous doppler showed no evidence of DVT. Also, no thrombus was visualised in the inferior vena cava. CT pulmonary angiogram could not be done as she was unstable. Intravenous heparin infusion was given for anticoagulation. The size of the RV clot did not decrease even after 1 week of parenteral anticoagulation. Thrombolysis or percutaneous mechanical thrombectomy 2 or any other invasive procedures were not done as the patient's attendants were not willing except for mechanical ventilation. She was continued on mechanical ventilation and other supportive medical measures but her condition did not improve. COVID-19 is a thromboinflammatory disease that promotes thrombosis and coagulopathy. The mechanisms involved in the thrombus formation appear to be multifactorial. It is postulated that dysregulated immune responses mediated by inflammatory cytokines, lymphocyte cell death, hypoxia and endothelial damage are involved. 3 This case highlights the de novo occurrence of RV thrombus (type C), unlike other cases of RV thrombus in patients with COVID-19 due to the presence of DVT or vascular catheter. 4 5 According to the classification of the European Working Group on Echocardiography, three types of RV thrombus have been described. Type A thrombus is worm-shaped and extremely mobile. Type B are more or less immobile, non-specific clots resembling left heart thrombi. Type C thrombi resemble a myxoma and are highly mobile. 1 The present case shows type C thrombus seen in COVID-19-positive patients. ► The left ventricular thrombus seen in patients with COVID-19 is usually due to ventricular dysfunction. Right heart thrombus is due to thromboembolism from deep vein thrombosis. Isolated de novo right ventricular thrombus in patients with COVID-19 is rare. ► Echocardiography is an effective, easy-to-use and valuable bedside imaging test for diagnosis and assessment of prognosis in such patients. ► Additional therapy with extracorporeal membrane oxygenation may be beneficial in such critically ill patients. Contributors SK-concept, literature search, manuscript editing, management of the patient and supervision of the case. DJ-literature search, data acquisition, manuscript editing, management of the patient, figure and video designing, and editing. SB-overall management and supervision of the case. SR-data acquisition, overall management and supervision of the case. The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Competing interests None declared. Patient consent for publication Next of kin consent obtained. Provenance and peer review Not commissioned; externally peer reviewed. This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy. Dilip Johny http:// orcid. org/ 0000-0002-4922-2806 Srivatsa Raghothama http:// orcid. org/ 0000-0002-6751-5725 Video 2 Two-dimensional transthoracic echocardiography (modified view) shows the location of the right ventricular thrombus (marked in red arrow). Video 3 Three-dimensional transthoracic echocardiography of the right ventricular thrombus (marked in red arrow). The European cooperative study on the clinical significance of right heart thrombi A case report of a large intracardiac thrombus in a COVID-19 patient managed with percutaneous thrombectomy and right ventricular mechanical circulatory support The unique characteristics of COVID-19 coagulopathy A case report of polymerase chain Reaction-Confirmed COVID-19 in a patient with right ventricular thrombus and bilateral deep vein thrombosis Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation Copyright 2021 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit https://www.bmj.com/company/products-services/rights-and-licensing/permissions/ BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission.Become a Fellow of BMJ Case Reports today and you can: ► Submit as many cases as you like ► Enjoy fast sympathetic peer review and rapid publication of accepted articles ► Access all the published articles ► Re-use any of the published material for personal use and teaching without further permission If you have any further queries about your subscription, please contact our customer services team on +44 (0) 207111 1105 or via email at support@bmj.com.Visit casereports.bmj.com for more articles like this and to become a Fellow